Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

计划入组 385 人 · 首次发布于 2010 年 3 月 4 日

Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder

计划入组 84 人 · 首次发布于 2021 年 3 月 9 日

Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance

计划入组 40 人 · 首次发布于 2008 年 7 月 9 日

Armodafinil(Nuvigil)

C₁₅H₁₅NO₂S · Rx

Sodium oxybate(Lumryz, Xyrem, Xywav)

C₄H₇NaO₃

Metyrosine(Demser)

C₁₀H₁₃NO₃

Dottikon Exclusive Synthesis AG

Switzerland

Solriamfetol Shows Promise for Treating Excessive Sleepiness in Early Morning Shift Workers

FDA Grants Orphan Drug Exclusivity to LUMRYZ for Narcolepsy Treatment, Marking First Once-Nightly Oxybate Therapy

Viatris Acquires Aculys Pharma, Gains Rights to CNS Therapies Pitolisant and Spydia in Japan